News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,266 Results
Type
Article (70434)
Company Profile (195)
Press Release (662619)
Multimedia
Podcasts (147)
Webinars (25)
Section
Business (188839)
Career Advice (2829)
Deals (34506)
Drug Delivery (147)
Drug Development (84246)
Employer Resources (163)
FDA (16404)
Job Trends (15091)
News (332087)
Policy (32134)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
Academia (3011)
Academic (2)
Accelerated approval (47)
Adcomms (34)
Allergies (168)
Alliances (47806)
ALS (206)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (468)
Approvals (16721)
Artificial intelligence (668)
Autoimmune disease (263)
Automation (52)
Bankruptcy (317)
Best Places to Work (11715)
BIOSECURE Act (18)
Biosimilars (216)
Biotechnology (141)
Bladder cancer (191)
Brain cancer (76)
Breast cancer (755)
Cancer (5940)
Cardiovascular disease (472)
Career advice (2419)
Career pathing (46)
CAR-T (338)
CDC (65)
Celiac Disease (2)
Cell therapy (896)
Cervical cancer (46)
Clinical research (72427)
Collaboration (2075)
Company closure (6)
Compensation (992)
Complete response letters (89)
COVID-19 (2847)
CRISPR (105)
C-suite (1117)
Cystic fibrosis (156)
Data (7548)
Decentralized trials (3)
Denatured (51)
Depression (171)
Dermatology (64)
Diabetes (550)
Diagnostics (7128)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (42)
Drug discovery (323)
Drug pricing (224)
Drug shortages (30)
Duchenne muscular dystrophy (263)
Earnings (71845)
Editorial (70)
Employer branding (19)
Employer resources (144)
Events (113412)
Executive appointments (1126)
FDA (20047)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (33)
Funding (1717)
Gene editing (229)
Generative AI (58)
Gene therapy (688)
GLP-1 (1053)
Government (5110)
Grass and pollen (7)
Guidances (403)
Healthcare (19742)
HIV (77)
Huntington's disease (48)
IgA nephropathy (90)
Immunology and inflammation (280)
Immuno-oncology (95)
Indications (164)
Infectious disease (3191)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (282)
Interviews (540)
IPO (15971)
IRA (59)
Job creations (3700)
Job search strategy (2001)
JPM (67)
Kidney cancer (21)
Labor market (88)
Layoffs (633)
Leadership (43)
Legal (7290)
Liver cancer (106)
Longevity (29)
Lung cancer (794)
Lymphoma (421)
Machine learning (55)
Management (57)
Manufacturing (977)
MASH (187)
Medical device (13877)
Medtech (13965)
Mergers & acquisitions (19777)
Metabolic disorders (1452)
mRNA (212)
Multiple sclerosis (179)
NASH (17)
Neurodegenerative disease (392)
Neuropsychiatric disorders (107)
Neuroscience (3254)
Neurotech (1)
NextGen: Class of 2026 (6887)
Non-profit (4837)
Now hiring (36)
Obesity (671)
Opinion (331)
Ovarian cancer (213)
Pain (253)
Pancreatic cancer (295)
Parkinson's disease (357)
Partnered (34)
Patents (577)
Patient recruitment (656)
Peanut (64)
People (63443)
Pharmaceutical (38)
Pharmacy benefit managers (31)
Phase 1 (22741)
Phase 2 (31744)
Phase 3 (23451)
Pipeline (7722)
Policy (337)
Postmarket research (2893)
Preclinical (9984)
Press Release (68)
Prostate cancer (301)
Psychedelics (58)
Radiopharmaceuticals (337)
Rare diseases (1043)
Real estate (6472)
Recruiting (68)
Regulatory (25047)
Reports (45)
Research institute (2643)
Resumes & cover letters (421)
Rett syndrome (35)
RNA editing (20)
RSV (92)
Schizophrenia (172)
Series A (285)
Series B (207)
Service/supplier (10)
Sickle cell disease (114)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (47)
Startups (3643)
State (2)
Stomach cancer (21)
Supply chain (114)
Tariffs (82)
The Weekly (93)
Vaccines (1154)
Venture capital (96)
Weight loss (433)
Women's health (113)
Worklife (23)
Date
Last 7 days (745)
Last 30 days (2529)
Last 365 days (30237)
2026 (9821)
2025 (30283)
2024 (34534)
2023 (39060)
2022 (49987)
2021 (54765)
2020 (53912)
2019 (47673)
2018 (36314)
2017 (33064)
2016 (32633)
2015 (38293)
2014 (31469)
2013 (27673)
2012 (29343)
2011 (29473)
2010 (28285)
Location
Africa (933)
Alabama (93)
Alaska (7)
Arizona (305)
Arkansas (16)
Asia (43305)
Australia (7660)
California (12110)
Canada (3524)
China (1342)
Colorado (534)
Connecticut (549)
Delaware (380)
Europe (99650)
Florida (1817)
Georgia (419)
Hawaii (3)
Idaho (65)
Illinois (1037)
India (90)
Indiana (568)
Iowa (23)
Japan (502)
Kansas (126)
Kentucky (48)
Louisiana (42)
Maine (78)
Maryland (1596)
Massachusetts (8634)
Michigan (367)
Minnesota (679)
Mississippi (7)
Missouri (157)
Montana (35)
Nebraska (28)
Nevada (136)
New Hampshire (89)
New Jersey (3338)
New Mexico (30)
New York (3336)
North Carolina (1594)
North Dakota (10)
Northern California (5957)
Ohio (375)
Oklahoma (26)
Oregon (46)
Pennsylvania (2408)
Puerto Rico (29)
Rhode Island (48)
South America (1264)
South Carolina (74)
South Dakota (2)
Southern California (4817)
Tennessee (204)
Texas (2046)
United States (43762)
Utah (370)
Vermont (1)
Virginia (296)
Washington D.C. (77)
Washington State (1009)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
733,266 Results for "university of texas md anderson cancer center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems
January 19, 2026
·
3 min read
Press Releases
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia
October 2, 2025
·
4 min read
Press Releases
Ulrich Steidl, M.D., Ph.D., Named Director of Montefiore Einstein Comprehensive Cancer Center
April 8, 2026
·
4 min read
Press Releases
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
April 2, 2026
·
7 min read
Press Releases
Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)
April 9, 2026
·
3 min read
Press Releases
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
April 7, 2026
·
12 min read
Press Releases
Texas Children’s Hospital and UT MD Anderson Announce Joint Venture to End Childhood Cancer
February 19, 2025
·
4 min read
Press Releases
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
March 18, 2026
·
6 min read
Press Releases
NYU Langone Health Announces Gastrointestinal Cancer and Translational Research Leader Dr. Anirban Maitra as New Director of the Perlmutter Cancer Center
January 29, 2026
·
5 min read
Business
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
CureVac N.V. (Nasdaq:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and The University of Texas MD Anderson Cancer Center today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines.
April 16, 2024
·
8 min read
1 of 73,327
Next
